☰

Ronald Cohn - Publications

Affiliations: 
Human Genetics Johns Hopkins University, Baltimore, MD 
Area:
Genetics, Molecular Biology, Cell Biology
Tree Info Similar researchers PubMed Report error

51 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Rok M, Ying Wong TW, Maino E, Ahmed A, Yang G, Hyatt E, Lindsay K, Fatehi S, Marks R, Delgado-Olguín P, Ivakine EA, Cohn RD. Prevention of early-onset cardiomyopathy in exon 52-54 deletion mice by CRISPR-Cas9-mediated exon skipping. Molecular Therapy. Methods & Clinical Development. 30: 246-258. PMID 37545481 DOI: 10.1016/j.omtm.2023.07.004  0.367
2023 Fatehi S, Marks RM, Rok MJ, Perillat L, Ivakine EA, Cohn R. Advances in CRISPR/Cas9 Genome Editing for the Treatment of Muscular Dystrophies. Human Gene Therapy. PMID 37119122 DOI: 10.1089/hum.2023.059  0.324
2020 Wong TWY, Ahmed A, Yang G, Maino E, Steiman S, Hyatt E, Chan P, Lindsay K, Wong N, Golebiowski D, Schneider J, Delgado-Olguín P, Ivakine EA, Cohn RD. A novel mouse model of Duchenne muscular dystrophy carrying a multi-exonic deletion exhibits progressive muscular dystrophy and early-onset cardiomyopathy. Disease Models & Mechanisms. 13. PMID 32988972 DOI: 10.1242/dmm.045369  0.476
2019 Kemaladewi DU, Cohn RD. Development of therapeutic genome engineering in laminin-α2-deficient congenital muscular dystrophy. Emerging Topics in Life Sciences. 3: 11-18. PMID 33523194 DOI: 10.1042/ETLS20180059  0.368
2019 Kemaladewi DU, Bassi PS, Erwood S, Al-Basha D, Gawlik KI, Lindsay K, Hyatt E, Kember R, Place KM, Marks RM, Durbeej M, Prescott SA, Ivakine EA, Cohn RD. A mutation-independent approach for muscular dystrophy via upregulation of a modifier gene. Nature. PMID 31341277 DOI: 10.1038/s41586-019-1430-x  0.463
2019 Kemaladewi DU, Benjamin JS, Hyatt E, Ivakine EA, Cohn RD. Increased polyamines as protective disease modifiers in congenital muscular dystrophy. Human Molecular Genetics. 27: 1905-1912. PMID 29566247 DOI: 10.1093/hmg/ddy097  0.593
2019 Kemaladewi DU, Cohn RD. Development of therapeutic genome engineering in laminin-α2-deficient congenital muscular dystrophy Emerging Topics in Life Sciences. 3: 11-18. DOI: 10.1042/ETLS20180059  0.368
2017 Wong TWY, Cohn RD. Therapeutic Applications of CRISPR/Cas for Duchenne Muscular Dystrophy. Current Gene Therapy. PMID 29173172 DOI: 10.2174/1566523217666171121165046  0.336
2017 Kemaladewi DU, Maino E, Hyatt E, Hou H, Ding M, Place KM, Zhu X, Bassi P, Baghestani Z, Deshwar AG, Merico D, Xiong HY, Frey BJ, Wilson MD, Ivakine EA, ... Cohn RD, et al. Correction of a splicing defect in a mouse model of congenital muscular dystrophy type 1A using a homology-directed-repair-independent mechanism. Nature Medicine. PMID 28714989 DOI: 10.1038/Nm.4367  0.361
2017 Zou Y, Donkervoort S, Salo AM, Reghan Foley A, Barnes AM, Hu Y, Makareeva E, Leach ME, Mohassel P, Dastgir J, Deardorff MA, Cohn RD, DiNonno WO, Malfait F, Lek M, et al. P4HA1 mutations cause a unique congenital disorder of connective tissue involving tendon, bone, muscle and the eye. Human Molecular Genetics. PMID 28419360 DOI: 10.1093/Hmg/Ddx110  0.438
2016 Cohn RD, Dubowitz V. Duchenne muscular dystrophy: Ringo to the rescue? Neuromuscular Disorders : Nmd. 26: 5-6. PMID 26801251 DOI: 10.1016/j.nmd.2015.12.001  0.447
2016 Kemaladewi DU, Cohn RD. Exon Snipping in Duchenne Muscular Dystrophy Trends in Molecular Medicine. 22: 187-189. DOI: 10.1016/j.molmed.2016.01.007  0.314
2015 Dubowitz V, Cohn RD. Dystrophin and Duchenne dystrophy. Neuromuscular Disorders : Nmd. 25: 361-2. PMID 25890834 DOI: 10.1016/j.nmd.2015.03.013  0.41
2014 Auer DR, Sysa-Shah P, Bedja D, Simmers JL, Pak E, Dutra A, Cohn R, Gabrielson KL, Chakravarti A, Kapoor A. Generation of a cre recombinase-conditional Nos1ap over-expression transgenic mouse. Biotechnology Letters. 36: 1179-85. PMID 24563304 DOI: 10.1007/S10529-014-1473-X  0.745
2014 MacDonald EM, Andres-Mateos E, Mejias R, Simmers JL, Mi R, Park JS, Ying S, Hoke A, Lee SJ, Cohn RD. Denervation atrophy is independent from Akt and mTOR activation and is not rescued by myostatin inhibition. Disease Models & Mechanisms. 7: 471-81. PMID 24504412 DOI: 10.1242/Dmm.014126  0.827
2014 Ivakine EA, Cohn RD. Maintaining skeletal muscle mass: lessons learned from hibernation. Experimental Physiology. 99: 632-7. PMID 24443348 DOI: 10.1113/expphysiol.2013.074344  0.638
2014 Chrestian N, Dowling J, Amburgey K, Moraes T, Cohn R, Hawkins C, Halliday W, McAdam L, Biggar D, Vajsar J. G.P.47 Neuromuscular Disorders. 24: 808-809. DOI: 10.1016/J.Nmd.2014.06.061  0.391
2013 Xu R, Andres-Mateos E, Mejias R, MacDonald EM, Leinwand LA, Merriman DK, Fink RH, Cohn RD. Hibernating squirrel muscle activates the endurance exercise pathway despite prolonged immobilization. Experimental Neurology. 247: 392-401. PMID 23333568 DOI: 10.1016/J.Expneurol.2013.01.005  0.576
2013 Andres-Mateos E, Brinkmeier H, Burks TN, Mejias R, Files DC, Steinberger M, Soleimani A, Marx R, Simmers JL, Lin B, Finanger Hedderick E, Marr TG, Lin BM, Hourdé C, Leinwand LA, ... ... Cohn RD, et al. Activation of serum/glucocorticoid-induced kinase 1 (SGK1) is important to maintain skeletal muscle homeostasis and prevent atrophy. Embo Molecular Medicine. 5: 80-91. PMID 23161797 DOI: 10.1002/Emmm.201201443  0.813
2012 Andres-Mateos E, Mejias R, Soleimani A, Lin BM, Burks TN, Marx R, Lin B, Zellars RC, Zhang Y, Huso DL, Marr TG, Leinwand LA, Merriman DK, Cohn RD. Impaired skeletal muscle regeneration in the absence of fibrosis during hibernation in 13-lined ground squirrels. Plos One. 7: e48884. PMID 23155423 DOI: 10.1371/Journal.Pone.0048884  0.848
2012 MacDonald EM, Cohn RD. TGFβ signaling: its role in fibrosis formation and myopathies. Current Opinion in Rheumatology. 24: 628-34. PMID 22918531 DOI: 10.1097/BOR.0b013e328358df34  0.414
2012 Files DC, D'Alessio FR, Johnston LF, Kesari P, Aggarwal NR, Garibaldi BT, Mock JR, Simmers JL, DeGorordo A, Murdoch J, Willis MS, Patterson C, Tankersley CG, Messi ML, Liu C, ... ... Cohn RD, et al. A critical role for muscle ring finger-1 in acute lung injury-associated skeletal muscle wasting. American Journal of Respiratory and Critical Care Medicine. 185: 825-34. PMID 22312013 DOI: 10.1164/Rccm.201106-1150Oc  0.843
2012 Burks T, Lucas O, Andres-Mateos E, Marx R, Simmers J, Walston J, Cohn R. T.O.8 Age-dependent effects of angiotensin II blockade on disuse atrophy Neuromuscular Disorders. 22: 908. DOI: 10.1016/J.Nmd.2012.06.345  0.812
2012 MacDonald E, Simmers J, Andres-Mateos E, Mejias-Estevez R, Lee S, Cohn R. T.O.6 Myostatin inhibitor ActIIb rescues atrophy and protects muscle growth signaling pathways in immobilization but not denervation Neuromuscular Disorders. 22: 908. DOI: 10.1016/J.Nmd.2012.06.343  0.833
2012 Simmers JL, Chaerkady R, Hedderick EF, Marx R, Mejias R, Pandey A, Cohn R. G.P.84 Mislocalization of nNOS alters the interactions between nNOS and proteins involved with muscle contraction in steroid-induced myopathy Neuromuscular Disorders. 22: 837. DOI: 10.1016/J.Nmd.2012.06.118  0.834
2012 Cohn RD, Dietz HC. Molecular pathogenesis of skeletal muscle abnormalities in marfan syndrome Muscle. 2: 995-1001. DOI: 10.1016/B978-0-12-381510-1.00071-5  0.428
2011 Burks TN, Cohn RD. One size may not fit all: anti-aging therapies and sarcopenia. Aging. 3: 1142-53. PMID 22184279  0.834
2011 Abadir PM, Foster DB, Crow M, Cooke CA, Rucker JJ, Jain A, Smith BJ, Burks TN, Cohn RD, Fedarko NS, Carey RM, O'Rourke B, Walston JD. Identification and characterization of a functional mitochondrial angiotensin system. Proceedings of the National Academy of Sciences of the United States of America. 108: 14849-54. PMID 21852574 DOI: 10.1073/Pnas.1101507108  0.724
2011 Burks TN, Cohn RD. Role of TGF-β signaling in inherited and acquired myopathies. Skeletal Muscle. 1: 19. PMID 21798096 DOI: 10.1186/2044-5040-1-19  0.81
2011 Burks TN, Andres-Mateos E, Marx R, Mejias R, Van Erp C, Simmers JL, Walston JD, Ward CW, Cohn RD. Losartan restores skeletal muscle remodeling and protects against disuse atrophy in sarcopenia. Science Translational Medicine. 3: 82ra37. PMID 21562229 DOI: 10.1126/Scitranslmed.3002227  0.803
2011 Lisi EC, Cohn RD. Genetic evaluation of the pediatric patient with hypotonia: perspective from a hypotonia specialty clinic and review of the literature. Developmental Medicine and Child Neurology. 53: 586-99. PMID 21418198 DOI: 10.1111/j.1469-8749.2011.03918.x  0.38
2011 Finanger Hedderick EL, Simmers JL, Soleimani A, Andres-Mateos E, Marx R, Files DC, King L, Crawford TO, Corse AM, Cohn RD. Loss of sarcolemmal nNOS is common in acquired and inherited neuromuscular disorders. Neurology. 76: 960-7. PMID 21403107 DOI: 10.1212/Wnl.0B013E31821043C8  0.737
2011 Cohn RD. Muscle cramps and coffee Neuromuscular Disorders. 21: 311. PMID 21377365 DOI: 10.1016/j.nmd.2011.02.011  0.591
2010 Lee SJ, Lee YS, Zimmers TA, Soleimani A, Matzuk MM, Tsuchida K, Cohn RD, Barton ER. Regulation of muscle mass by follistatin and activins. Molecular Endocrinology (Baltimore, Md.). 24: 1998-2008. PMID 20810712 DOI: 10.1210/me.2010-0127  0.628
2010 Burks T, Andres-Mateos E, Simmers J, MacDonald E, van Erp C, Marx R, Cohn R. P3.47 Administration of Losartan improves skeletal muscle repair in mice with sarcopenia Neuromuscular Disorders. 20: 655. DOI: 10.1016/J.Nmd.2010.07.189  0.797
2010 Simmers J, Hedderick E, Andres-Mateos E, MacDonald E, Burks T, Marx R, Cohn R. P3.19 Decrease of sarcolemmal nNOS as a molecular marker of muscle atrophy in inherited and acquired forms of myopathy Neuromuscular Disorders. 20: 646-647. DOI: 10.1016/J.Nmd.2010.07.161  0.789
2009 Fontana S, Cohn RD. SP-litting the satellite niche to repopulate muscle. Cell Stem Cell. 4: 194-5. PMID 19265654 DOI: 10.1016/J.Stem.2009.02.002  0.351
2007 Cohn RD, van Erp C, Habashi JP, Soleimani AA, Klein EC, Lisi MT, Gamradt M, ap Rhys CM, Holm TM, Loeys BL, Ramirez F, Judge DP, Ward CW, Dietz HC. Angiotensin II type 1 receptor blockade attenuates TGF-beta-induced failure of muscle regeneration in multiple myopathic states. Nature Medicine. 13: 204-10. PMID 17237794 DOI: 10.1038/Nm1536  0.397
2007 Cohn RD, van Erp C, Habashi JP, Soleimani AA, Klein EC, Lisi MT, Gamradt M, ap Rhys CM, Holm TM, Loeys BL, Ramirez F, Judge DP, Ward CW, Dietz HC. Erratum: Corrigendum: Angiotensin II type 1 receptor blockade attenuates TGF-β–induced failure of muscle regeneration in multiple myopathic states Nature Medicine. 13: 511-511. DOI: 10.1038/Nm0407-511A  0.459
2005 Cohn RD. Dystroglycan: important player in skeletal muscle and beyond. Neuromuscular Disorders : Nmd. 15: 207-17. PMID 15725582 DOI: 10.1016/j.nmd.2004.11.005  0.349
2005 Cohn RD. Corrigendum to “Dystroglycan: important player in skeletal muscle and beyond” [Neuromuscular Disorders 15 (2005) 207–217] Neuromuscular Disorders. 15: 573. DOI: 10.1016/j.nmd.2005.06.015  0.51
2002 Cohn RD, Henry MD, Michele DE, Barresi R, Saito F, Moore SA, Flanagan JD, Skwarchuk MW, Robbins ME, Mendell JR, Williamson RA, Campbell KP. Disruption of DAG1 in differentiated skeletal muscle reveals a role for dystroglycan in muscle regeneration. Cell. 110: 639-48. PMID 12230980 DOI: 10.1016/S0092-8674(02)00907-8  0.602
2002 Michele DE, Barresi R, Kanagawa M, Saito F, Cohn RD, Satz JS, Dollar J, Nishino I, Kelley RI, Somer H, Straub V, Mathews KD, Moore SA, Campbell KP. Post-translational disruption of dystroglycan-ligand interactions in congenital muscular dystrophies. Nature. 418: 417-22. PMID 12140558 DOI: 10.1038/Nature00837  0.385
2001 Voit T, Kutz P, Leube B, Neuen-Jacob E, Schröder JM, Cavallotti D, Vaccario ML, Schaper J, Broich P, Cohn R, Baethmann M, Göhlich-Ratmann G, Scoppetta C, Herrmann R. Autosomal dominant distal myopathy: further evidence of a chromosome 14 locus. Neuromuscular Disorders. 11: 11-19. PMID 11166161 DOI: 10.1016/S0960-8966(00)00158-9  0.39
2001 Cohn RD, Durbeej M, Moore SA, Coral-Vazquez R, Prouty S, Campbell KP. Prevention of cardiomyopathy in mouse models lacking the smooth muscle sarcoglycan-sarcospan complex. The Journal of Clinical Investigation. 107: R1-7. PMID 11160141 DOI: 10.1172/Jci11642  0.425
2000 Cohn RD, Campbell KP. Molecular basis of muscular dystrophies. Muscle & Nerve. 23: 1456-71. PMID 11003781 DOI: 10.1002/1097-4598(200010)23:10<1456::Aid-Mus2>3.0.Co;2-T  0.532
2000 Durbeej M, Cohn RD, Hrstka RF, Moore SA, Allamand V, Davidson BL, Williamson RA, Campbell KP. Disruption of the beta-sarcoglycan gene reveals pathogenetic complexity of limb-girdle muscular dystrophy type 2E. Molecular Cell. 5: 141-51. PMID 10678176 DOI: 10.1016/S1097-2765(00)80410-4  0.505
2000 Flanigan KM, Kerr L, Bromberg MB, Leonard C, Tsuruda J, Zhang P, Gonzalez-Gomez I, Cohn R, Campbell KP, Leppert M. Congenital muscular dystrophy with rigid spine syndrome: a clinical, pathological, radiological, and genetic study. Annals of Neurology. 47: 152-61. PMID 10665485 DOI: 10.1002/1531-8249(200002)47:2<152::Aid-Ana4>3.0.Co;2-U  0.46
1999 Coral-Vazquez R, Cohn RD, Moore SA, Hill JA, Weiss RM, Davisson RL, Straub V, Barresi R, Bansal D, Hrstka RF, Williamson R, Campbell KP. Disruption of the sarcoglycan-sarcospan complex in vascular smooth muscle: a novel mechanism for cardiomyopathy and muscular dystrophy. Cell. 98: 465-74. PMID 10481911 DOI: 10.1016/S0092-8674(00)81975-3  0.517
1999 Cohn RD, Mayer U, Saher G, Herrmann R, van der Flier A, Sonnenberg A, Sorokin L, Voit T. Secondary reduction of alpha7B integrin in laminin alpha2 deficient congenital muscular dystrophy supports an additional transmembrane link in skeletal muscle. Journal of the Neurological Sciences. 163: 140-52. PMID 10371075 DOI: 10.1016/S0022-510X(99)00012-X  0.367
1999 von Moers A, van Landeghem FK, Cohn RD, Baumgarten E, Bürger J, Stoltenburg-Didinger G. Dystrophinopathy in a boy with Chediak-Higashi syndrome. Neuromuscular Disorders : Nmd. 8: 489-94. PMID 9829279 DOI: 10.1016/S0960-8966(98)00062-5  0.4
Show low-probability matches.